Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/successful-antiviral-treatment-for-fulminant-reactivated-hepatitis-b-O6EUy0tIOc
References (37)
-
W. Yeo, J. Steinberg, J. Tam, P. Chan, N. Leung, K. Lam, T. Mok, P. Johnson (1999)
Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapyJournal of Medical Virology, 59
-
M. Picardi, C. Selleri, G. Rosa, A. Raiola, L. Pezzullo, B. Rotoli (1998)
Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantationBone Marrow Transplantation, 21
-
(1981)
Effects of immunosuppressive therapy in chronic active hepatitis B -
J. Dienstag, R. Perrillo, E. Schiff, M. Bartholomew, C. Vicary, M. Rubin (1995)
A preliminary trial of lamivudine for chronic hepatitis B infection.The New England journal of medicine, 333 25
-
G. Davis, J. Hoofnagle (1987)
Reactivation of chronic hepatitis B virus infection.Gastroenterology, 92 6
-
B. Korba (1996)
In vitro evaluation of combination therapies against hepatitis B virus replication.Antiviral research, 29 1
-
L. Rostaing, Sabine Henry, J. Cisterne, Michel Duffaut, Josette Icart, Dominique Durand (1997)
Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation.Transplantation, 64 11
-
M. Bartholomew, R. Jansen, L. Jeffers, K. Reddy, L. Johnson, H. Bunzendahl, Lynn Condreay, A. Tzakis, EugeneR. Schiff, N. Brown (1997)
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationThe Lancet, 349
-
C. Lai, C. Ching, A. Tung, E. Li, J. Young, A. Hill, B. Wong, J. Dent, P. Wu (1997)
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo‐controlled trialHepatology, 25
-
George Lau, Raymond Liang, Pui Wu, Cheuk-Kwong Lee, Wei Lim, Wing Au (1998)
Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.Journal of hepatology, 28 3
-
(2000)
A ONE-YEAR TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS B -
Heiner Wedemeyer, Klaus B??ker, K. Pethig, D. Petzold, Peer Flemming, H. Tillmann, J. Vollmar, Murat Bast??rk, Ekaterina Goldmann, K. Griffin, A. Haverich, Michael Manns (1999)
Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.Transplantation, 68 10
-
J. Main, J. Brown, C. Howells, R. Galassini, M. Crossey, P. Karayiannis, P. Georgiou, G. Atkinson, H. Thomas (1996)
A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infectionJournal of Viral Hepatitis, 3
-
P. Honkoop, R. Man, H. Niesters, S. Schalm (1998)
Clinical impact of lamivudine resistance in chronic hepatitis B.Journal of hepatology, 29 3
-
M. Melegari, P. Scaglioni, J. Wands (1998)
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defectiveHepatology, 27
-
P. Honkoop, H. Niesters, R. Man, A. Osterhaus, S. Schalm (1997)
Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.Journal of hepatology, 26 6
-
J. Lau, Ching‐lung Lai, H. Lin, A. Lok, R. Liang, P. Wu, T. Chan, D. Todd (1989)
Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients.The Quarterly journal of medicine, 73 270
-
O. Al-Taie, H. Mörk, A. Gassel, M. Wilhelm, B. Weissbrich, Michael Scheurlen (1999)
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literatureAnnals of Hematology, 78
-
R. Liang, R. Liang, A. Lok, Ching. Lai, T. Chan, D. Todd, E. Chiu (1990)
Hepatitis B infection in patients with lymphomasHematological Oncology, 8
-
L. Wolters, P. Honkoop, H. Niesters, R. Man (1998)
Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.Journal of hepatology, 28 5
-
Raymond Liang, George Lau, Y. Kwong (1999)
Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 1
-
Klaus Böker, Burkhard Ringe, M. Krüger, R. Pichlmayr, Michael Manns (1994)
Prostaglandin E plus famciclovir--a new concept for the treatment of severe hepatitis B after liver transplantation.Transplantation, 57 12
-
R. Myers, M. Swain, S. Urbanski, S. Lee (2001)
Reactivation of hepatitis B e antigen-negative chronic hepatitis B in a bone marrow transplant recipient following lamivudine withdrawal.Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 15 9
-
Cliona Maguire, D. Crawford, L. Hourigan, A. Clouston, E. Walpole, E. Powell (1999)
C ASE R EPORT: Lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapyJournal of Gastroenterology and Hepatology, 14
-
F. Clark, M. Drummond, S. Chambers, B. Chapman, W. Patton (1998)
Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.Annals of oncology : official journal of the European Society for Medical Oncology, 9 4
-
A. Bartholomeusz, L. Groenen, S. Locarnini (1997)
Clinical experience with famciclovir against hepatitis B virus.Intervirology, 40 5-6
-
M. Krüger, H. Tillmann, C. Trautwein, U. Bode, K. Oldhafer, H. Maschek, K. Böker, C. Broelsch, R. Pichlmayr, M. Manns (1996)
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2 4
-
J. Dienstag, E. Schiff, T. Wright, R. Perrillo, H. Hann, Z. Goodman, L. Crowther, Lynn Condreay, M. Woessner, M. Rubin, N. Brown (1999)
Lamivudine as initial treatment for chronic hepatitis B in the United States.The New England journal of medicine, 341 17
-
George Lau, Raymond Liang, E. Chiu, Cheuk-Kwong Lee, Shiu Lam (1997)
Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled studyBone Marrow Transplantation, 19
-
F. Borg, Suzanne Smorenburg, R. Man, R. Rietbroek, R. Chamuleau, E. Jones (1998)
Case Report: Recovery from Life-Threatening, Corticosteroid-Unresponsive, Chemotherapy-Related Reactivation of Hepatitis B Associated with Lamivudine TherapyDigestive Diseases and Sciences, 43
-
G. Tipples, M. Ma, K. Fischer, V. Bain, N. Kneteman, D. Tyrrell (1996)
Mutation in HBV RNA‐dependent DNA polymerase confers resistance to lamivudine in vivoHepatology, 24
-
D. Colledge, S. Locarnini, T. Shaw (1997)
Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitroHepatology, 26
-
Aijaz Ahmed, E. Keeffe (1999)
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infectionAmerican Journal of Gastroenterology, 94
-
E. Jaeckel, M. Manns (1997)
Experience with lamivudine against hepatitis B virus.Intervirology, 40 5-6
-
S. Strasser, G. McDonald (1999)
Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management.Blood, 93 4
-
P. Honkoop, H. Niesters, R. Man, A. Osterhaus, S. Schalm (1997)
Lamivudine resistance inimmunocompetent chronic hepatitis BJournal of Hepatology, 26
-
N. Rayes, D. Seehofer, W. Bechstein, A. Müller, T. Berg, R. Neuhaus, P. Neuhaus (1999)
Long‐term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantationClinical Transplantation, 13
- Publisher
- Springer Journals
- Copyright
- Copyright © 2002 by Springer-Verlag
- Subject
- Legacy
- ISSN
- 0939-5555
- eISSN
- 1432-0584
- DOI
- 10.1007/s00277-002-0469-0
- pmid
- 12107567
- Publisher site
- See Article on Publisher Site
Abstract
The risk of severe hepatic damage due to reactivation of hepatitis B virus (HBV) infection after intensive myelosuppressive chemotherapy is well known. Two of the most evolved nucleotide analogues showing good activity against the hepatitis B virus are lamivudine and famciclovir. We report the successful therapeutic use of lamivudine and famciclovir for fulminant reactivated hepatitis B after autologous peripheral blood stem cell transplantation (PBSCT) and the subsequent prophylactic use of lamivudine during allogeneic blood stem cell transplantation (alloSCT) for chronic lymphocytic leukemia (CLL) in a 40-year-old patient. Antiviral therapy was well tolerated and no hematotoxicity occurred. Our observation warrants further investigation of antiviral therapy with famciclovir and lamivudine in HBV carriers receiving intensive myelosuppressive chemotherapy.
Journal
Annals of Hematology – Springer Journals
Published: Jun 1, 2002